deltatrials
Completed PHASE4 NCT02170532

Aerosolized Beta-Agonist Isomers in Asthma

Sponsor: Duke University

Conditions Asthma
Interventions aerochamber max breath actuated nebulizer ipratroprium levalbuterol levalbuterol MDI saline
Updated 8 times since 2017 Last updated: Aug 11, 2014 Started: Jul 31, 2007 Primary completion: Jul 31, 2009 Completion: Jul 31, 2009

Listed as NCT02170532, this PHASE4 trial focuses on Asthma and remains completed. Sponsored by Duke University, it has been updated 8 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  2. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

  3. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Duke University
Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.